Advertisement

Topics

Achillion Pharmaceuticals Company Profile

04:19 EDT 22nd September 2017 | BioPortfolio

Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, with a particular emphasis on antiviral drugs to treat diseases caused by hepatitis B and C viruses (HBV and HCV), HIV and herpes viruses.

Product Candidate Portfolio

The Company’s broad drug development pipeline includes antiviral compounds licensed from Yale University as well as those developed using our proprietary Zinc Finger Targeting (ZFT) technology. Achillion focuses on developing drugs to treat diseases caused by:



• Human immunodeficiency virus (HIV)

• Hepatitis B virus (HBV)

• Hepatitis C virus (HCV) • Herpes viruses

• Bacteria

• Fungi

Location

300 George Street
New Haven
06511
United States of America

Contact

Phone: (203) 624 7000
Fax: (203) 624 7003
Email: keastwood@achillion.com


News Articles [1285 Associated News Articles listed on BioPortfolio]

Achillion Pharmaceuticals, Inc. (ACHN) Expected to Post Earnings of -$0.16 Per Share

Equities research analysts forecast that Achillion Pharmaceuticals, Inc. will announce earnings per share of for the current fiscal quarter, according to Zacks Investment Research . Zero analysts have...

ACHTUNG Kurseinbruch bei Achillion Pharmaceuticals-Aktie! - Aktiennews

Bad Marienberg - +++ ACHTUNG +++ Kurseinbruch bei Achillion Pharmaceuticals-Aktie! - Aktiennews Achillion Pharmaceuticals-Aktienanalyse des Analysten Brian Skorney von Robert W. Baird: Der Aktienku...

Analysts Expect Achillion Pharmaceuticals, Inc. (ACHN) Will Announce Earnings of -$0.16 Per Share

Brokerages expect that Achillion Pharmaceuticals, Inc. will post earnings of per share for the current quarter, according to Zacks Investment Research . Zero analysts have provided estimates for Achil...

Why Achillion Pharmaceuticals Is Shooting 25% Higher Today

After the company updated investors on its second-quarter financials and the progress it's making in its clinical-stage drug pipeline, shares in Achillion Pharmaceuticals in 2015, Achillion Pharma...

J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion's stock

Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to develop the firm’s hepatitis C drug pipeline. The news sent Achillion’s stock re...

Achillion Pharmaceuticals (ACHN) - Pipeline advancing

Edison Investment Research - Pharmaceutical & healthcare - Achillion Pharmaceuticals: Achillion recently announced that its partner, Janssen, has fully enrolled its 365-patient Phase IIb trial testing...

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) Lowered to "Strong Sell" at BidaskClub

Several other analysts also recently commented on the company. Robert W. Baird raised their target price on Achillion Pharmaceuticals from $5.00 to $10.00 and gave the company an "outperform" rating i...

Achillion Pharmaceuticals (ACHN) Given Daily Coverage Optimism Score of 0.30

Headlines about Achillion Pharmaceuticals have trended positive this week, according to Accern. The research group identifies negative and positive media coverage by reviewing more than 20 million blo...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [155 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Clinical Trials [200 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1280 Associated Companies listed on BioPortfolio]

Achillion

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The Company’s discovery and development teams have advanced mult...

Achillion Pharmaceuticals

Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, ...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Achillion Pharmaceuticals" on BioPortfolio

We have published hundreds of Achillion Pharmaceuticals news stories on BioPortfolio along with dozens of Achillion Pharmaceuticals Clinical Trials and PubMed Articles about Achillion Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Achillion Pharmaceuticals Companies in our database. You can also find out about relevant Achillion Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record